Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches-Reference-Cited by-同舟云学术

Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches

Published:2019-03 Issue: Volume:12 Page:124-137
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Duong MyLinh T.,Collinson-Pautz Matthew R.,Morschl Eva,Lu An,Szymanski Slawomir P.,Zhang Ming,Brandt Mary E.,Chang Wei-Chun,Sharp Kelly L.,Toler Steven M.,Slawin Kevin M.,Foster Aaron E.,Spencer David M.,Bayle J. Henri

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference54 articles.

1. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci. Transl. Med.,2014

2. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients;Turtle;J. Clin. Invest.,2016

3. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N. Engl. J. Med.,2013

4. Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia;Park;N. Engl. J. Med.,2018

5. Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas;Schuster;N. Engl. J. Med.,2017

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of CAR transgene expression to design semiautonomous CAR-T;Molecular Therapy: Oncology;2024-09

2. Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers;Cytotherapy;2024-08

3. Rationalizing Diverse Binding Mechanisms to the Same Protein Fold: Insights for Ligand Recognition and Biosensor Design;ACS Chemical Biology;2024-07-17

4. Engineering programmable CAR-T cells with tunable controls as fail-safe mechanisms during cancer immunotherapy;2024-07-10

5. Gene therapy in pediatrics – Clinical studies and approved drugs (as of 2023);Life Sciences;2024-07